comparemela.com

Believes About News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Study Finds Infliximab Biosimilar Switch Is Safe, Effective for Patients with IBD

Switching from biosimilar CT-P13 to SB2 is safe and effective, according to new research. The patients in the study had no significant changes in their psychometric assessments during the 12 month follow up.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.